Vision Disorders: Clinical Trials

2 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Withdrawn 2
Phase 2	2	Withdrawn 2

Follow Vision Disorders: new trials by email Literature Review of Vision Disorders trials Research Report on Vision Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Docosahexaenoic Acid (DHA) Supplementation in Amblyopia Docosahexaenoic Acid, Placebo Oral Tablet - Amblyopia	Phase 1 / Phase 2	Withdrawn	Johns Hopkins University		2024-01-01	2024-02-09
Caffeine in Amblyopia Study Caffeine - Amblyopia	Phase 1 / Phase 2	Withdrawn	Johns Hopkins University		2014-10-01	2017-03-07

Narrower conditions

Amblyopia (2)

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Eye Diseases (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sensation Disorders (2)  ·  Signs and Symptoms (2)

Interventions

Caffeine (1)  ·  Docosahexaenoic Acids (1)

Sponsors

Johns Hopkins University (2)

Countries

United States (2)

Top investigators

Courtney Kraus, MD (1)  ·  Michael X Repka, MD, MBA (1)